推荐产品
方案
≥98% (HPLC)
表单
solid
颜色
light yellow
溶解性
DMSO: ~5 mg/mL
创始人
Bristol-Myers Squibb
SMILES字符串
O[C@H](C(O)=O)c1ccccc1.Oc2ccc3C[C@@H]4C5CCCC[C@]5(CCN4CC6CCC6)c3c2
InChI
1S/C21H29NO.C8H8O3/c23-17-8-7-16-12-20-18-6-1-2-9-21(18,19(16)13-17)10-11-22(20)14-15-4-3-5-15;9-7(8(10)11)6-4-2-1-3-5-6/h7-8,13,15,18,20,23H,1-6,9-12,14H2;1-5,7,9H,(H,10,11)/t18?,20-,21-;7-/m10/s1
InChI key
CBWUCCIELNNDND-QADVRDRQSA-N
生化/生理作用
κ/μ opioid receptor agonist.
特点和优势
This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
警示用语：
Warning
危险声明
预防措施声明
危险分类
Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
J L Neumeyer et al.
Journal of medicinal chemistry, 43(1), 114-122 (2000-01-14)
This report concerns the synthesis and preliminary pharmacological evaluation of a novel series of kappa agonists related to the morphinan (-)-cyclorphan (3a) and the benzomorphan (-)-cyclazocine (2) as potential agents for the pharmacotherapy of cocaine abuse. Recent evidence suggests that
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门